Acute-phase Treatment and Prevention of Large Coronary Artery Lesions in Kawasaki Disease

Toshimasa Nakada
Department of Pediatrics, Aomori Prefectural Central Hospital, Higashi- tukurimiti 2-1-1, Aomori City, Aomori Prefecture, Japan.

SKU: ATPLCALKD Category: Tags: ,

Book Details

Author(s)

Toshimasa Nakada

Pages

32

Publisher

B P International

Language

English

ISBN-13 (15)

978-93-5547-267-0 (Print)
978-93-5547-269-4 (eBook)

Published

November 01, 2021

About The Author / Editor

Toshimasa Nakada

Department of Pediatrics, Aomori Prefectural Central Hospital, Higashi- tukurimiti 2-1-1, Aomori City, Aomori Prefecture, Japan.

I encountered an outbreak of Kawasaki disease (KD) in Japan on 1982. Aspirin therapy was a sole treatment for the disease, and many children had severe coronary artery lesions (CALs) on 1982. Currently, we have been able to utilize an intravenous immunoglobulin (IVIG) therapy for KD, and the prevalence of CALs caused by KD have been decreasing. However, an effective use of IVIG therapy for the prevention of severe CALs has not been established yet. In this book, I have reviewed findings of clinical trials conducted in our department regarding acute-phase treatment and prevention of severe CALs in KD.